Mesoblast’s Revascor gets US FDA’s regenerative medicine advanced therapy designation in children with congenital heart disease: New York Friday, December 6, 2024, 18:00 Hrs [ ...

Lexi Boult was born with hypoplastic left heart syndrome (HLHS ... messages' as leaders of 'Manc J' line Doctors needed to repair the narrowed artery at the bottom of Lexi's heart and wait ...

FDA granted REVASCOR both Rare Pediatric Disease Designation (RPDD) and Orphan-Drug Designation (ODD) for congenital heart disease. NEW YORK, Dec. 04, 2024 (GLOB ...